logo
logo
Sign in

Embolic Agents Is Fastest Growing Segment Fueling The Growth Of Embolization Market

avatar
Gauri Cmi
Embolic Agents Is Fastest Growing Segment Fueling The Growth Of Embolization Market


The global Embolization Market is estimated to be valued at US$ 1810.94 Mn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Embolization procedures are minimally invasive treatments performed to reduce or block blood flow to an area of the body. During the procedure, surgeons thread a catheter through an artery to deliver embolic agents like gel foam particles or liquid polymers that plug the blood vessel and stop blood flow. This prevents blood from feeding tumors or aneurysms.

Market key trends:

One of the key trends in the embolization market is growing preference for embolic agents over traditional surgical procedures. Embolization is less invasive than open surgery and allows for reduced procedure time, less risk of infection, and a quicker recovery. Moreover, advanced embolic agents can be accurately placed using minimally invasive catheter procedures and image guidance systems. This has increased the uptake of embolization procedures for treating tumors, vascular malformations, and aneurysms.

Segment Analysis

The global embolization market is segmented based on product, procedure, application, end-user, and region. Based on product, the embolization market is segmented into embolic agents, embolization devices, and accessories. The embolic agents segment dominated the global market in 2020 as it is widely used during various interventional radiology procedures. Access to advanced embolic agents and increasing adoption of minimally invasive procedures are fueling the growth of this segment.

Key Takeaways

The Global Embolization Market Size is expected to witness high growth, exhibiting CAGR of 8.1% over the forecast period, due to increasing preference for minimally invasive procedures over traditional surgeries.

Regional analysis

North America dominated the global market in 2020 with a share of over 40%, followed by Europe and Asia Pacific. Rising geriatric population, growing prevalence of diseases requiring embolization, and high adoption of advanced technologies drive the growth of these regional markets. The Asia Pacific region is expected to witness the fastest growth owing to growing healthcare infrastructure and medical tourism in the region.

Key players

Key players operating in the embolization market are IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson. Boston Scientific Corporation holds the leading market position due to its wide product portfolio for embolization.

 

Get More Insights On This Topic: https://www.pressreleasebulletin.com/global-embolization-market/


collect
0
avatar
Gauri Cmi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more